![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | (2006.01) |
A61K 9/1617 | (2013.01) | ||
A61K 47/18 | (2017.01) | ||
A61K 9/1652 | (2013.01) | ||
A61K 9/2013 | (2013.01) | ||
A61K 9/16 | (2006.01) | ||
A61K 9/2077 | (2013.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/2086 | (2013.01) | ||
A61K 9/24 | (2006.01) | ||
A61K 31/155 | (2006.01) | ||
A61K 9/209 | (2013.01) | ||
A61K 31/522 | (2006.01) | ||
A61K 9/2095 | (2013.01) | ||
A61P 3/04 | (2006.01) | ||
A61K 31/155 | (2013.01) | ||
A61P 3/10 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 19/10 | (2006.01) | ||
A61K 9/2027 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61K 31/522 | (2013.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 19/10 | (2018.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 3/04 | (2018.01) | ||
A61P 37/06 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 3/10 | (2018.01) |
(11) | Number of the document | 3453403 |
(13) | Kind of document | T |
(96) | European patent application number | 18195610.3 |
Date of filing the European patent application | 2009-04-02 | |
(97) | Date of publication of the European application | 2019-03-13 |
(45) | Date of publication and mention of the grant of the patent | 2025-01-22 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
08154039 | 2008-04-03 | EP | |
87343 P | 2008-08-08 | US |
(72) |
FRIEDL, Thomas , DE
BRAUN, Michael , DE
EGUSA, Kenji , DE
FUJITA, Hikaru , DE
MARUYAMA, Megumi , JP
NISHIOKA, Takaaki , DE
|
(73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
(54) | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION |
DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION |